MONTREAL-(BUSINESS WIRE)- Veteranen op het gebied van diergezondheid en experts op het gebied van menselijke tandheelkunde hebben hun krachten gebundeld en een beginnend bedrijf opgericht dat zich toelegt op de ontwikkeling van superieure mondverzorgingsproducten voor gezelschapsdieren. Momenteel worden niet-invasieve producten voor het verwijderen van tandsteen ontwikkeld, waarbij gebruik wordt gemaakt van een exclusieve, gepatenteerde technologie.

Het nieuwe bedrijf, DENTALIS Animal Health, heeft zijn hoofdkantoor in Montreal en wordt geleid door:

• CEO David Hauptman
• President en Product Development Director Kevin McDonnell, serie-ondernemer en mede-oprichter van TetraGenx Animal Heath, Provetica AH en Vetio AH.
• Chief Scientific Officer Hansruedi Siegrist, ex Global Head of Technical Development bij Novartis Animal Health and Management Consultant bij Elanco AH.
• Directeur regelgevende zaken, Jennifer (Rice) Thayer. Oprichter van Knotty Tide Consulting

DENTALIS Animal Health Develops Products to Improve the Oral Health of Companion Animals

MONTREAL–(BUSINESS WIRE)– Animal health veterans and human dental experts have combined and formed a start-up company dedicated to the development of superior oral health care products for companion animals, currently developing non-invasive tartar removal products, using an exclusive demonstrated patented technology.

The new company, DENTALIS Animal Health, is headquartered in Montreal and is led by:

• CEO David Hauptman
• President and Product Development Director Kevin McDonnell, serial entrepreneur and co founder of TetraGenx Animal Heath, Provetica AH and Vetio AH.
• Chief Scientific Officer Hansruedi Siegrist , ex Global Head of Technical Development at Novartis Animal Health and Management Consultant at Elanco AH.
• Regulatory Affairs Director , Jennifer (Rice) Thayer. Founder of Knotty Tide Consulting

“The DENTALIS AH team with its impressive track record will use the novel technology to develop superior oral health care products for companion animals,” Said President Kevin McDonnell

Three products are in development, DENTALIS reported.

McDonnell predicted fast growth for DENTALIS.

“By mid 2024, assuming positive development results, DENTALIS expects its first product to be approved and forecasts potential revenues up to $25 million in its first commercial year,” he said.

About DENTALIS

We strive to discover new ways to improve and extend our companion animal’s lives through science based oral health innovation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220930005472/en/

Contacts

David Hauptman

David@dentalis.ca
1-514-578-0345